• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓间充质干细胞衍生的外泌体 Egr2 通过直接上调 SIRT6 抑制 Notch 信号来改善缺血性中风。

BMSC-Derived Exosomal Egr2 Ameliorates Ischemic Stroke by Directly Upregulating SIRT6 to Suppress Notch Signaling.

机构信息

Department of Neurosurgery, Central South University Xiangya School of Medicine Affiliated Haikou Hospital, Haikou, 570208, Hainan Province, People's Republic of China.

出版信息

Mol Neurobiol. 2023 Jan;60(1):1-17. doi: 10.1007/s12035-022-03037-5. Epub 2022 Oct 8.

DOI:10.1007/s12035-022-03037-5
PMID:36208355
Abstract

Exosomes generated by BMSCs contribute to functional recovery in ischemic stroke. However, the regulatory mechanism is largely unknown. Exosomes were isolated from BMSCs. Tube formation, MTT, TUNEL, and flow cytometry assays were applied to examine cell angiogenesis, viability, and apoptosis. Protein and DNA interaction was evaluated by ChIP and luciferase assays. LDH release into the culture medium was examined. Infarction area was evaluated by TTC staining. Immunofluorescence staining was applied to examine CD31 expression. A mouse model of MCAO/R was established. BMSC-derived exosomes attenuated neuronal cell damage and facilitated angiogenesis of brain endothelial cells in response to OGD/R, but these effects were abolished by the knockdown of Egr2. Egr2 directly bound to the promoter of SIRT6 to promote its expression. The incompetency of Egr2-silencing exosomes was reversed by overexpression of SIRT6. Furthermore, SIRT6 inhibited Notch signaling via suppressing Notch1. Overexpression of SIRT6 and inhibition of Notch signaling improved cell injury and angiogenesis in OGD/R-treated cells. BMSC-derived exosomal Egr2 ameliorated MCAO/R-induced brain damage via upregulating SIRT6 to suppress Notch signaling in mice. BMSC-derived exosomes ameliorate OGD/R-induced injury and MCAO/R-caused cerebral damage in mice by delivering Egr2 to promote SIRT6 expression and subsequently suppress Notch signaling. Our study provides a potential exosome-based therapy for ischemic stroke.

摘要

BMSC 来源的外泌体有助于缺血性脑卒中的功能恢复。然而,其调控机制在很大程度上尚不清楚。我们从 BMSC 中分离出外泌体。通过管形成、MTT、TUNEL 和流式细胞术检测来评估细胞血管生成、活力和凋亡。通过 ChIP 和荧光素酶检测评估蛋白质和 DNA 相互作用。通过测定 LDH 释放到培养基中来评估其损伤。通过 TTC 染色评估梗死面积。通过免疫荧光染色检测 CD31 表达。建立 MCAO/R 小鼠模型。BMSC 来源的外泌体减轻了 OGD/R 诱导的神经元细胞损伤,并促进了脑内皮细胞的血管生成,但这些作用被 Egr2 的敲低所消除。Egr2 直接与 SIRT6 的启动子结合以促进其表达。通过过表达 SIRT6 逆转了 Egr2 沉默外泌体的无能。此外,SIRT6 通过抑制 Notch1 抑制 Notch 信号。过表达 SIRT6 和抑制 Notch 信号改善了 OGD/R 处理细胞中的细胞损伤和血管生成。BMSC 来源的外泌体 Egr2 通过上调 SIRT6 抑制 Notch 信号来改善 MCAO/R 诱导的脑损伤,从而在小鼠中减轻脑缺血再灌注损伤。BMSC 来源的外泌体通过向细胞内递送 Egr2 来促进 SIRT6 表达,从而抑制 Notch 信号,从而改善 OGD/R 诱导的损伤和 MCAO/R 引起的脑损伤,为缺血性脑卒中提供了一种潜在的基于外泌体的治疗方法。

相似文献

1
BMSC-Derived Exosomal Egr2 Ameliorates Ischemic Stroke by Directly Upregulating SIRT6 to Suppress Notch Signaling.骨髓间充质干细胞衍生的外泌体 Egr2 通过直接上调 SIRT6 抑制 Notch 信号来改善缺血性中风。
Mol Neurobiol. 2023 Jan;60(1):1-17. doi: 10.1007/s12035-022-03037-5. Epub 2022 Oct 8.
2
Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway.骨髓间充质干细胞来源的外泌体 microRNA-29b-3p 通过激活 PTEN 介导的 Akt 信号通路预防大鼠脑缺氧缺血损伤。
J Neuroinflammation. 2020 Feb 3;17(1):46. doi: 10.1186/s12974-020-1725-8.
3
Bone Marrow Mesenchymal Stem Cell-Derived Exosomal KLF4 Alleviated Ischemic Stroke Through Inhibiting N6-Methyladenosine Modification Level of Drp1 by Targeting lncRNA-ZFAS1.骨髓间充质干细胞衍生的外泌体 KLF4 通过靶向 lncRNA-ZFAS1 抑制 Drp1 的 N6-甲基腺苷修饰水平缓解缺血性脑卒中。
Mol Neurobiol. 2023 Jul;60(7):3945-3962. doi: 10.1007/s12035-023-03301-2. Epub 2023 Mar 31.
4
Bone marrow mesenchymal stem cell-derived exosomes carrying long noncoding RNA ZFAS1 alleviate oxidative stress and inflammation in ischemic stroke by inhibiting microRNA-15a-5p.携带长链非编码RNA ZFAS1的骨髓间充质干细胞来源外泌体通过抑制微小RNA-15a-5p减轻缺血性中风中的氧化应激和炎症。
Metab Brain Dis. 2022 Oct;37(7):2545-2557. doi: 10.1007/s11011-022-00997-4. Epub 2022 Jul 30.
5
Bone marrow mesenchymal stem cell-derived exosomal miR-193b-5p reduces pyroptosis after ischemic stroke by targeting AIM2.骨髓间充质干细胞衍生的外泌体 miR-193b-5p 通过靶向 AIM2 减少缺血性中风后的细胞焦亡。
J Stroke Cerebrovasc Dis. 2023 Aug;32(8):107235. doi: 10.1016/j.jstrokecerebrovasdis.2023.107235. Epub 2023 Jun 30.
6
Exosomes Released from Bone-Marrow Stem Cells Ameliorate Hippocampal Neuronal Injury Through transferring miR-455-3p.骨髓间充质干细胞来源的外泌体通过转移 miR-455-3p 减轻海马神经元损伤。
J Stroke Cerebrovasc Dis. 2022 Aug;31(8):106142. doi: 10.1016/j.jstrokecerebrovasdis.2021.106142. Epub 2022 May 19.
7
USP18 Stabilized FTO Protein to Activate Mitophagy in Ischemic Stroke Through Repressing m6A Modification of SIRT6.USP18 通过抑制 SIRT6 的 m6A 修饰稳定 FTO 蛋白,从而激活缺血性中风中的自噬。
Mol Neurobiol. 2024 Sep;61(9):6658-6674. doi: 10.1007/s12035-024-04001-1. Epub 2024 Feb 10.
8
Energy restriction induced SIRT6 inhibits microglia activation and promotes angiogenesis in cerebral ischemia via transcriptional inhibition of TXNIP.能量限制诱导的 SIRT6 通过转录抑制 TXNIP 抑制小胶质细胞激活并促进脑缺血中的血管生成。
Cell Death Dis. 2022 May 11;13(5):449. doi: 10.1038/s41419-022-04866-x.
9
Exosomes Derived from Bone Marrow Mesenchymal Stem Cells Promote Angiogenesis in Ischemic Stroke Mice via Upregulation of MiR-21-5p.骨髓间充质干细胞来源的外泌体通过上调 miR-21-5p 促进缺血性脑卒中小鼠的血管生成。
Biomolecules. 2022 Jun 24;12(7):883. doi: 10.3390/biom12070883.
10
MiR-370 accelerated cerebral ischemia reperfusion injury via targeting SIRT6 and regulating Nrf2/ARE signal pathway.miR-370 通过靶向 SIRT6 并调节 Nrf2/ARE 信号通路加速脑缺血再灌注损伤。
Kaohsiung J Med Sci. 2020 Sep;36(9):741-749. doi: 10.1002/kjm2.12219. Epub 2020 Apr 20.

引用本文的文献

1
BMSCs-derived exosomal Egr2 inhibited OGD/R-induced neuronal cell injury through the RNF8/DAPK1 axis in ischemic stroke.骨髓间充质干细胞来源的外泌体Egr2通过RNF8/DAPK1轴抑制缺血性脑卒中中氧糖剥夺/复氧诱导的神经元细胞损伤。
Exp Brain Res. 2025 Jun 26;243(7):181. doi: 10.1007/s00221-025-07127-3.
2
In vitro and In vivo Studies on Mesenchymal Stem Cells for Ischemic Stroke Therapy: A Scoping Review of The Therapeutic Effect.间充质干细胞治疗缺血性中风的体外和体内研究:治疗效果的范围综述
Stem Cells Cloning. 2025 May 31;18:45-61. doi: 10.2147/SCCAA.S519338. eCollection 2025.
3
Potential therapeutic targets for ischemic stroke in pre-clinical studies: Epigenetic-modifying enzymes DNMT/TET and HAT/HDAC.
临床前研究中缺血性中风的潜在治疗靶点:表观遗传修饰酶DNMT/TET和HAT/HDAC。
Front Pharmacol. 2025 Apr 28;16:1571276. doi: 10.3389/fphar.2025.1571276. eCollection 2025.
4
Sequential construction of vascularized and mineralized bone organoids using engineered ECM-DNA-CPO-based bionic matrix for efficient bone regeneration.使用基于工程化细胞外基质-脱氧核糖核酸-钙磷寡聚物的仿生基质进行血管化和矿化骨类器官的顺序构建以实现高效骨再生。
Bioact Mater. 2025 Mar 14;49:362-377. doi: 10.1016/j.bioactmat.2025.02.033. eCollection 2025 Jul.
5
Regenerative properties of bone marrow mesenchymal stem cell derived exosomes in rotator cuff tears.骨髓间充质干细胞来源外泌体在肩袖撕裂中的再生特性
J Transl Med. 2025 Jan 12;23(1):47. doi: 10.1186/s12967-024-06029-2.
6
Exosomal miR-486 derived from bone marrow mesenchymal stem cells promotes angiogenesis following cerebral ischemic injury by regulating the PTEN/Akt pathway.骨髓间充质干细胞来源的外泌体 miR-486 通过调控 PTEN/Akt 通路促进脑缺血损伤后血管生成。
Sci Rep. 2024 Aug 5;14(1):18086. doi: 10.1038/s41598-024-69172-2.
7
Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases.外泌体作为神经退行性疾病的治疗和药物传递载体。
J Nanobiotechnology. 2024 Aug 2;22(1):463. doi: 10.1186/s12951-024-02681-4.
8
Advancing stroke therapy: innovative approaches with stem cell-derived extracellular vesicles.推进中风治疗:干细胞衍生的细胞外囊泡的创新方法。
Cell Commun Signal. 2024 Jul 22;22(1):369. doi: 10.1186/s12964-024-01752-1.
9
Emerging Roles of Exosomes in Stroke Therapy.外泌体在中风治疗中的新作用。
Int J Mol Sci. 2024 Jun 13;25(12):6507. doi: 10.3390/ijms25126507.
10
Engineered exosomes enriched with select microRNAs amplify their therapeutic efficacy for traumatic brain injury and stroke.富含特定微小RNA的工程化外泌体可增强其对创伤性脑损伤和中风的治疗效果。
Front Cell Neurosci. 2024 Mar 19;18:1376601. doi: 10.3389/fncel.2024.1376601. eCollection 2024.